BMO Capital Markets Begins Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT)
BMO Capital Markets assumed coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Wednesday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $50.00 target price on the biotechnology company’s stock. RCKT has been the topic of a number of other research reports. Chardan Capital dropped […]
BMO Capital Markets assumed coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Free Report) in a report released on Wednesday morning, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $50.00 target price on the biotechnology company’s stock. RCKT has been the topic of a number of other research reports. Chardan Capital dropped […]
